Trade Summary
3 days ago, Mutz Christopher, serving as HEAD OF RARE DISEASE at Ani Pharmaceuticals Inc (ANIP), sold 417 shares at $74.00 per share, for a total transaction value of $30,858.00. Following this transaction, Mutz Christopher now holds 103,508 shares of ANIP.
The trade was executed on Monday, March 2, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 4, 2026, 2 days after the trade was made.
Ani Pharmaceuticals Inc operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.